GPHL attended corporate exchange event in Sichuan, strategic cooperation agreement signed

GPHL 2018-05-10 10:58:27

A strategic cooperation agreement has been signed between GPHL and Sichuan Province, mainly about further cooperation in TCM, health care, commerce, and medical treatment.

GPHL signs strategic cooperation agreements with Gansu Province

GPHL 2018-05-10 10:56:17

The visit took place after GPHL signed two strategic cooperation agreements with Gansu Province during the Gansu Investment Promotion Conference at Zhudao Hotel in Guangzhou on April 24.

GPHL records a year-on-year growth of 36.71% in net profit in 2017

GPHL 2018-03-21 16:00:06

China’s leading pharmaceuticals enterprise GPHL reported an operating income of 20.954 billion RMB in 2017, up 4.58% year-on-year, and a net profit of 2.062 billion RMB, up 36.71%.

GPHL launched new product—Wang Lao Cola in Davos

GPHL 2018-03-05 17:08:32

GPHL launched a brand new product—Wang Lao Cola at the 48th World Economic Forum (WEF) Annual Meeting in Davos, Switzerland.

GPHL gains clinical trial permission for class 1.1 new drug Ceftriamidine Sodium

GPHL 2018-03-05 17:06:41

On the evening of Jan. 1, GPHL announced that it has received permission from the China Food and Drug Administration to conduct clinical trials with their class 1.1 new drug Ceftriamidine Sodium.

GPHL attends the China (Guangdong)-U.K. Economic and Trade Cooperation Conference

GPHL 2017-09-27 16:15:30

During the Conference, GPHL conferred with international pharmaceutical giants including Teva Pharmaceutical Industries Limited, the largest generic drug manufacturer and Walgreens Boots Alliance.

Hu Chunhua meets with chairman of GPHL and CEO of WBA

GPHL 2017-09-13 17:20:55

The strategic cooperation between GPHL and WBA was first established in 2007.

Baiyunshan Hanfang Botanical Anti-tumor Drug has been CEP approved by EDOM

GPHL 2017-09-13 17:13:26

Recently, GPHL has made exciting breakthroughs in terms of TCM modernization and internationalization. Baiyunshan Hanfang Botanical Anti-tumor Drug has been CEP approved by EDOM.

NULL